Hints and tips:
Related Special Reports
...As well as proceeds from its Covid products, Pfizer has also benefited from the spin-off of its Upjohn generics business, which combined with Mylan to form Viatris in late 2020....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...After raking in billions of dollars through sales of the Covid vaccine it co-developed with Germany’s BioNTech during the pandemic and seeing share prices surge, Pfizer has struggled to reorientate its pipeline...
Case studies in best practice among general counsel and company legal teams in North America
...So a new report from S&P Global Ratings on payment-in-kind bonds – aka PIKs – is going to really irritate them....
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
...In a statement, Pfizer said the alleged conduct was a “violation of the company’s policies” and that it was “co-operating with the government’s investigation”....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...The drugmakers Pfizer and Roche said they are piloting use of rFC at some of their facilities....
...Job moves JPMorgan Chase has hired John China — the president of Silicon Valley Bank’s venture capital arm SVB Capital — as co-head of innovation economy based in San Francisco....
...The 19 drugs that are due to come to market this year and next are a mix of candidates developed by Pfizer scientists and external prospects acquired through bolt-on acquisitions or co-developed via partnerships...
...According to European officials, national healthcare systems in Europe are favouring Pfizer’s Paxlovid, another Covid antiviral pill, whose efficacy in reducing death and hospitalisation has been confirmed...
...A co-ordinated protest by those moderators has created a blackout on the site....
...Prometheus comes just weeks after Pfizer spent $43bn acquiring SeaGen, a maker of cancer treatments, previously pursued by Merck. Late last year, Amgen bought Horizon Therapeutics for $28bn....
...Eli Lilly, Amgen, Pfizer and Regeneron are among the companies aiming to compete with market leader Novo Nordisk in a category which analysts say is rapidly becoming a healthcare priority and could produce...
...In March Pfizer swooped on Seagen, announcing a deal for a total enterprise value of $43bn, which was the largest pharmaceutical transaction announced since AbbVie agreed to buy Allergan in 2019....
...China’s elites are stockpiling supplies of Paxlovid, Pfizer’s Covid-19 antiviral drug, and giving it away to curry favour with business associates as an unprecedented Covid wave leaves hospitals stripped...
...Haleon, GlaxoSmithKline’s consumer healthcare venture with Pfizer, is down about 5 per cent from its July listing price....
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...The companies said on Monday they were recruiting 6,000 people aged 5 years and older for the phase 3 trial of the co-developed vaccine, the only Lyme disease jab undergoing tests on humans....
...And as the irreplaceable Joseph Wang (aka the Fed Guy) pointed out to me, while that problem did cause a wave of withdrawals at other banks, those other banks were able to source new liquidity, from the...
...Pfizer said the 60 microgram dose produced an immune response that was three times higher than the existing BioNTech/Pfizer vaccine....
...Hence why, in the latest episode, they could easily push through the vote for Kendall and Roman to become co-CEOs....
International Edition